Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2005
12/20/2005CA2176962C N-substituted azabicycloheptane derivatives, their preparation and use
12/20/2005CA2114007C Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
12/15/2005WO2005119315A2 Non-linear optically active molecules, their synthesis, and use
12/15/2005WO2005118578A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118575A1 Non nucleoside reverse transcriptase inhibitors
12/15/2005WO2005118556A1 Propane-1,3-dione derivative or its salt
12/15/2005WO2005118547A1 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005118537A2 Arylpiperazine derivatives as adrenergic receptor antagonists
12/15/2005WO2005118535A1 Substituted pyrrolidine-2-ones
12/15/2005WO2005117908A2 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases
12/15/2005WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005WO2005117543A2 N-sulfonylcarboximidamide apoptosis promoters
12/15/2005WO2004098590A8 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/15/2005US20050277686 Benzimidazole compounds for regulating IgE
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277663 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277640 Pyrimidine derivatives for treatment of hyperproliferative disorders
12/15/2005US20050277638 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
12/15/2005US20050277637 Arylindenopyridines and related therapeutic and prophylactic methods
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005US20050277628 Substituted thiophene carboxamides
12/15/2005DE102004026026A1 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia
12/15/2005CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005CA2567831A1 N-sulfonylcarboximidamide apoptosis promoters
12/15/2005CA2566187A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005CA2565705A1 Non-linear optically active molecules, their synthesis, and use
12/15/2005CA2565689A1 Substituted pyrrolidine-2-ones
12/14/2005EP1604988A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1603897A1 Pyrazole compounds useful in the treatment of inflammation
12/14/2005EP1603893A1 Ep4 receptor antagonists
12/14/2005EP1603885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors
12/14/2005EP1603883A2 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/14/2005EP1603881A2 Substituted thiophenes with antibacterial activity
12/14/2005EP1603874A2 G-lactam derivatives as prostaglandin agonists
12/14/2005EP1603572A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
12/14/2005EP1603570A2 Aminoheteroaryl compounds as protein kinase inhibitors
12/14/2005EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
12/14/2005EP1326858B1 Piperidine compounds as anti-allergic
12/14/2005EP1119562B1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005CN1708496A Cyclopropyl-thienyl-carboxamide as fungicides
12/14/2005CN1708479A Novel compounds useful in treating PPAR mediated diseases
12/14/2005CN1708306A Quinazolinone compounds as calcilytics
12/14/2005CN1706841A 1-(4,4-diaryl-3-butene)-piperidine formic acid or its medicine salt, prepn process and application
12/14/2005CN1231762C Method for directly identifying candidate compound
12/14/2005CN1231476C Substd. pyridine herbicides
12/14/2005CN1231473C Substituted arylpyrazines
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/13/2005US6974831 sPLA2 inhibitors
12/13/2005US6974827 For use as pesticides and herbicides
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/13/2005CA2250930C 4-[(thien-3-yl)methyl] imidazole derivatives having .alpha.2-adrenoceptor agonistic activity
12/08/2005WO2005117242A1 Method and installation means for installing an electrical machine
12/08/2005WO2005116012A1 Pyrrolidine derivative
12/08/2005WO2005116010A1 Ep4 receptor agonist, compositions and methods thereof
12/08/2005WO2005116009A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
12/08/2005WO2005115992A1 Theramutein modulators
12/08/2005WO2005115990A1 Cinnamide compound
12/08/2005WO2005115984A2 Large conductance calcium-activitated k channel opener
12/08/2005WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists
12/08/2005WO2005115976A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005WO2005115975A1 Arylalkylamines and process for production thereof
12/08/2005WO2005115148A1 3-aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides
12/08/2005WO2005115145A2 Quinone substituted quinazoline and quinoline kinase inhibitors
12/08/2005WO2005087724A3 Sulphonylpyrroles as hdac inhibitors
12/08/2005WO2005077932A3 Chemokine receptor antagonists
12/08/2005WO2004099126A8 N-(2-PHENYLETHYL)SULFAMIDE DERIVATIVES AS INTEGRIN α4 ANTAGONISTS
12/08/2005WO2004098589A8 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/08/2005WO2004093798A3 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272791 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
12/08/2005US20050272785 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
12/08/2005US20050272780 Small molecule inhibitors of rotamase enzyme activity
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272744 N-((4-((( 1R)-3 -(dimethylamino)-1-((phenylsulfanyl)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-4-(4-(2-fluorobenzyl)-4-methoxy-1-piperidinyl)benzenecarboximidamide; trigger apoptosis through the inhibition of the Bcl family of proteins
12/08/2005US20050272740 Benzimidazole derivatives
12/08/2005US20050272728 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272699 1- and 2-substituted with carbo- or heterocyclic groups, e.g., 3-[4-(5-Difluoromethoxy-3-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2-fluoro-phenyl)-acrylonitrile; inhibit the production of IL-2.
12/08/2005US20050272663 Novel substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
12/08/2005US20050272036 Ketones
12/08/2005CA2568046A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005CA2567813A1 Theramutein modulators
12/08/2005CA2566094A1 Cinnamide compound
12/08/2005CA2564668A1 Pyrrolidine derivatives
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1601664A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders
12/07/2005EP1601659A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
12/07/2005EP1601657A1 Pyrazole modulators of atp-binding cassette transporters
12/07/2005EP1601654A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides
12/07/2005EP1601653A1 Process for the production of substituted nicotinic acid esters
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 523